Clinical Trial Update: Mass-balance Study of [14C]-APD421 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 mass-balance study of radiolabeled APD421 in healthy volunteers evaluating pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-operative Nausea and Vomiting

Drugs mentioned

• APD421

Snippet

Sponsor: Acacia Pharma Ltd | Conditions: Post-operative Nausea and Vomiting | Phase 1 | Status: COMPLETED | Results posted: 2019-06-07